Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SDHB | P21912 | 13/20 | 0.59 |
| ▸ | TP53 | P04637 | 5/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | STAT3 | P40763 | 3/20 | 0.36 |
| ▸ | STAT1 | P42224 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21019832 | 0.88 | SDHB (0.66) | SDHBTP53SMN1; SMN2POLBSTAT3 | |
| SCHEMBL20985729 | 0.84 | SDHB (0.81) | SDHBTP53SMN1; SMN2POLBSTAT3 | |
| SCHEMBL20985724 | 0.82 | SDHB (0.63) | SDHBTP53SMN1; SMN2POLBSTAT3 | |
| SCHEMBL20985651 | 0.80 | SDHB (0.64) | SDHBTP53SMN1; SMN2POLBSTAT3 | |
| SCHEMBL21020171 | 0.80 | SDHB (0.69) | SDHBTP53MAPT | |
| SCHEMBL20985693 | 0.78 | SDHB (0.65) | SDHBTP53SMN1; SMN2MAPT | |
| SCHEMBL20985674 | 0.78 | SDHB (0.61) | SDHBTP53SMN1; SMN2POLBSTAT3 | |
| SCHEMBL20985719 | 0.76 | SDHB (0.62) | SDHBTP53SMN1; SMN2MAPT | |
| SCHEMBL26312667 | 0.76 | SDHB (0.63) | SDHBTP53MAPT | |
| SCHEMBL19806001 | 0.74 | SDHB (1.00) | SDHBTP53SMN1; SMN2POLBSTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11034680-B2 | Apoptosis inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2021-06-15 | — | — | US | disclosed |
| US-20190152960-A1 | Apoptosis Inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152960-A1 | Apoptosis Inhibitors | BAX, SDHA, SDHB | SDHB 3/4885TP53 160/4885SMN1; SMN2 1698/4885 |
| US-11034680-B2 | Apoptosis inhibitors | BAX, SDHA, SDHB | SDHB 3/4885TP53 160/4885SMN1; SMN2 1698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.